<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Act 1934
Date of Report (Date of earliest event reported) February 5, 1999
----------------
Respironics, Inc.
-----------------
(Exact name of registrant as specified in its charter)
Delaware 000-16723 25-1304989
- ---------------------------------------------------------------------
State or other jurisdiction Commission IRS Employer
of incorporation File Number identification
Employees
1501 Ardmore Boulevard, Pittsburgh PA 15221-4401
- ---------------------------------------------------------------------
(Address of principal executive officers) (Zip)
Registrant's telephone number, including area code (412) 731-2100
--------------
- ---------------------------------------------------------------------
(Former name and former address, if changed since last report)
<PAGE>
Item 1. Changes in Control of Registrant
None
Item 2. Acquisition or Disposition of Assets.
None
Item 3. Bankruptcy or Receivership.
None
Item 4. Changes in Registrant's Certifying Accountant.
None
Item 5. Other Events.
On February 5, 1999, the Company announced that James W. Liken
and J. Paul Yokubinas had been appointed to the Company's Board
of Directors for terms extending through 2000 and 1999,
respectively. The appointments, which were effective January
28, 1999, expand the membership of the Board to eleven
directors.
Item 6. Resignation of Registrant's Directors.
None
Item 7. Financial Statements and Exhibits.
None.
<PAGE>
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Respironics, Inc.
-----------------------------------
(Registrant)
2/19/99 /s/James C. Woll
------- -----------------------------------
(Date) (Signature)
James C. Woll
Vice President -
Corporate Controller
